
About Dexcom
Dexcom is a publicly listed company based in San Diego (United States) founded in 1999. Wearable glucose monitoring patches are provided for real-time data tracking. It operates in the Healthcare and Technology sectors. Dexcom has raised $52.5 million across 8 funding rounds from investors including HHS, Warburg Pincus and Canaan. The company has 10,300 employees. Dexcom has completed 2 acquisitions, including SweetSpot Diabetes and TypeZero Technologies. Its chief executive, as recorded, is Kevin Sayer. Its website dexcom.com draws about 2.8 million monthly visits. Dexcom offers products and services including Dexcom G7 and Dexcom App. Its focus areas include Life Sciences, Diabetes, Medical Devices and Monitoring Devices. Its legal entity is Dexcom, Inc. Its competitors include Livongo, Senseonics and One Drop; 3 of its 3 listed competitors have raised funding.
Company details
Dexcom was founded in 1999 in San Diego, United States, and operates in the medical device sector focused on diabetes management. A wearable patch is offered that measures glucose levels continuously, with data transmitted wirelessly to a receiver or display device for real-time viewing. In 2022, revenues reached 3.02 billion, while net profit was recorded at 0.29 billion. The companys products support ongoing monitoring without frequent finger pricks.
- Annual Revenue$4.66 B (USD)15.6as on Dec 31, 2025
- Net Profit$836.3 M (USD)45.14as on Dec 31, 2025
- EBITDA$1.16 B (USD)42.3as on Dec 31, 2025
- Total Equity Funding$52.5M (USD)
in 8 rounds
- Latest Funding Round$1.05B (USD), Post-IPO
Apr 2020
- InvestorsHHS
& 4 more
- Employee Count10,300
- Investments & AcquisitionsSweetSpot Diabetes
& 1 more
Products & Services of Dexcom
Dexcom offers a comprehensive portfolio of products and services, including Dexcom G7 and Dexcom App.
Real-time glucose monitoring device that reduces fingerstick needs.
App for viewing glucose data on smartphones and smartwatches.
Apps and channels of Dexcom
Dexcom publishes 3 mobile apps with over 2M+ downloads; its YouTube channel Dexcom Canada - English has 53 subscribers and 30 videos.
Videos from Dexcom
The most watched videos on Dexcom's YouTube channel, Dexcom Canada - English (53 subscribers). Click a video to play it here.
More on Dexcom Canada - English.
Funding Insights of Dexcom
Dexcom has successfully raised a total of $52.5M across 8 strategic funding rounds. The most recent funding activity was a Post-IPO round of $1.05 billion completed in April 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $52.5M
- Total Rounds 8
- Last Round Post-IPO β $1.05B
- First Round $30M
(Jun 2002)
- Investors Count 5
All 8 funding rounds of Dexcom with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2020 | $1.05B | Post-IPO | β | β | β |
| Dec 2018 | $850M | Post-IPO | β | β | β |
| May 2016 | $7.23M | Post-IPO | β | β | β |
| Sep 2014 | $224,354 | Grant | β | β | |
| Apr 2012 | $3.96M | Post-IPO | β | β | β |
| Feb 2005 | $235,498 | Debt – Convertible | β | β | β |
| Jan 2005 | $22.5M | Series D | β | β | |
| Jun 2002 | $30M | Series C | β | β |
5 investors in total: 5 institutional.
Investors in Dexcom
Dexcom has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Warburg Pincus and Canaan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multi-stage private equity investments are pursued across diverse sectors. | 1966 | warburgpincus.com | New York, United States | |
Canaan is recognized as an early-stage venture capital firm. | 1987 | canaan.com | San Francisco, United States | |
Early-stage investments are made in US life-sciences and tech companies. | rwiventures.com | Menlo Park, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Fund based investment management firm and fund of funds focused on multiple sectors | 1935 | invescomutualfund.com | Mumbai, India |
Investor details for Dexcom
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Dexcom
707 people are tracked at Dexcom (160 in leadership, 9 in board & advisors, 538 in team); the tracked headcount is 10,300.
| Name | Role | Group |
|---|---|---|
Kevin Sayer | CEO & President | Leadership |
Terri Chera | Sr. Director Of Software Product And Technical Program Management At Dexcom | Leadership |
Ryan Lindeman | Director Of Process Engineering | Leadership |
Wendy Lundy | Staff TA Sourcing Partner | Leadership |
Gabriel Altmayer | Director Of New Business Development & Strategic Finance | Leadership |
Roxana Heitz | VP Of Product | Leadership |
Matthew Johnson | Senior Director Clinical Science | Leadership |
Suyang Ooi | Senior Director Of Engineering | Leadership |
Caitlin Taylor | Director Of Manufacturing | Leadership |
Jereme Sylvain | EVP & CFO | Leadership |
Joshua Windmiller | Head Of New Analytes And Sensing Platforms | Leadership |
Mindy Kaur Sohal | Uk/emea Regional Business Partner, Talent Acquisition & Engagement | Leadership |
Mark Mydland | VP SW Development Engineering🔹lead 100+ Engineers🔹integrating AI With Mobile🔹speed With Quality | Leadership |
Jan Kupfer | Senior Director Legal EMEA | Leadership |
Athena Pallares | Director Of Financial Reporting | Leadership |
Brennen Crawford | Finance Director - Global Revenue, Pricing, & Reporting | Leadership |
Aime Fausz | Director Of Engineering | Leadership |
Michael Brown | Executive Vice President And Chief Legal Officer | Leadership |
Donald Abbey | Executive Vice President | Leadership |
Bhupesh Mahendru | Vice President Of Global Quality Assurance | Leadership |
687 more people are available in the full profile.
Complete people profiles for Dexcom
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Dexcom
Dexcom is a publicly listed company on the NASDAQ with ticker symbol DXCM in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date14 Apr 2005
- Listed onNASDAQ: DXCM
- Listed entityDexCom, Inc.
- Exchange sectorHealth technology
- ISINUS2521311074
- Share price$85.06 (-1% on the day) · 2026-10-13
- Market capitalisation$32.10B
- Price to earnings33.6
- EPS (diluted, trailing year)$2.53
- Volume (last session)4,017,079
Financials of Dexcom
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $4.66B | $836.3M | $1.16B |
| 2024 | $4.03B | $576.2M | $817.7M |
| 2023 | $3.62B | $541.5M | $783.7M |
| 2022 | $2.91B | $341.2M | $547.1M |
| 2021 | $2.45B | $216.9M | $367.7M |
Detailed financial statements for Dexcom
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dexcom
Dexcom has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include SweetSpot Diabetes and TypeZero Technologies.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Device for continuous glucose monitoring with manually operated insulin delivery | typezero.com | Charlottesville, United States | 2013 | Aug 2018 | $11.3M | |
Platform to aggregate and analyze blood glucose data from devices | sweetspotdiabetes.com | Portland, United States | 2009 | Feb 2012 | $8.5M |
Complete acquisition details for Dexcom
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Dexcom
6 dated milestones of Dexcom across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Dexcom is founded.
- Funding First funding round of $30.0M.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires SweetSpot Diabetes.
- Acquisition Acquires TypeZero Technologies.
- Funding Latest funding round, Post-IPO, of $1.1B.
Competitors of Dexcom
Dexcom has 3 listed competitors in our database, 3 of them funded. They include Livongo, Senseonics and One Drop.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| livongo.com | 2014 | San Francisco, United States | $237M | 3,263 | Provider of smart devices for diabetes management for patients and doctors | |
| senseonics.com | 1996 | Germantown, United States | $175.46M | 132 | Implantable continuous glucose monitoring systems are provided for diabetes management. | |
| onedrop.today | 2015 | New York, United States | $107.87M | 166 | Provider of workforce healthcare solutions |
Detailed competitors of Dexcom
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Dexcom
The website of Dexcom (dexcom.com) receives about 2.8M visits a month and ranks #19,957 among all websites worldwide, #428 in Health Conditions and Concerns.
- Monthly visits2.8M
▲ 6.1% vs previous month
- Unique visitors1.3M
per month
- Global rank#19,957
among all websites
- Category rank#428
Health · Health Conditions and Concerns
- Bounce rate47%
- Pages per visit3.9
- Average visit1 min 59 sec
- DevicesDesktop 38% Β· Mobile 62%
Websites whose visitors overlap most with Dexcom. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
freestyle.abbott | freestyle.abbott | 100% | #23,505 | β | |
| libreview.com | 84% | #50,343 | View details | ||
medtronicdiabetes.com | medtronicdiabetes.com | 78% | #198,048 | β | |
| omnipod.com | 76% | #42,515 | View details | ||
| diabetes.org | 76% | 1.4M | #43,191 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Dexcom
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Diabetes
3 companies that operate in the same segment as Dexcom (Diabetes) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Small molecule drugs for various therapeutic areas are developed. | 1995 | United States | USD 165 M | USD 49.8 M | 103 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dexcom
Complete news archive for Dexcom
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dexcom
Dexcom was founded in 1999 and raised its 1st funding round 3 years after it was founded.
Dexcom is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Kevin Sayer is the CEO of Dexcom, as recorded in our data.
Dexcom is a funded company, having raised a total of $52.5M across 8 funding rounds to date. The company's 1st funding round was a Series C of $30M, raised on Jun 2002.
Dexcom has 10,300 employees.
Annual revenue of Dexcom is $4.66B as on Dec 31, 2025.
Dexcom was founded in 1999 in San Diego, United States, and operates in the medical device sector focused on diabetes management. A wearable patch is offered that measures glucose levels continuously, with data transmitted wirelessly to a receiver or display device for real-time viewing. In 2022, revenues reached 3.02 billion, while net profit was recorded at 0.29 billion. The companys products support ongoing monitoring without frequent finger pricks.
Dexcom's top competitors include Senseonics, One Drop and Livongo.
Dexcom offers Dexcom G7 and Dexcom App.
Yes, Dexcom is publicly traded on NASDAQ under the ticker symbol DXCM.
Dexcom has made 2 acquisitions, including SweetSpot Diabetes, and TypeZero Technologies.
Dexcom has 5 investors. Key investors include HHS, Warburg Pincus, Canaan, Invesco Mutual Fund, and RWI Ventures.
